Recommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 Diabetes

Overview

Journal Clin Diabetes

Specialty Endocrinology

Date 2022 Feb 28

PMID 35221479

Authors

Ines H Vieira

Luisa M Barros

Carla F Baptista

Dircea M Rodrigues

Isabel M Paiva

Affiliations

Soon will be listed here.

Citing Articles

Assessment of Metformin Intolerance: A Retrospective Chart Review.

Murphy P, Bramwell-Shittu A, Boehmer K, Painter J, Mahashabde R Innov Pharm. 2024; 15(3).

PMID: 39483503 PMC: 11524218. DOI: 10.24926/iip.v15i3.5779.

Metformin: Diverse molecular mechanisms, gastrointestinal effects and overcoming intolerance in type 2 Diabetes Mellitus: A review.

Mohamed S Medicine (Baltimore). 2024; 103(43):e40221.

PMID: 39470509 PMC: 11521032. DOI: 10.1097/MD.0000000000040221.

The Association between Vitamin D Status and the Impact of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Women with Subclinical Hypothyroidism.

Krysiak R, Kowalcze K, Szkrobka W, Okopien B Pharmaceutics. 2024; 16(8).

PMID: 39204438 PMC: 11360748. DOI: 10.3390/pharmaceutics16081093.

Metformin-Induced Nightmares: An Uncommon Event.

Modi B, Suravajjala D, Case J, Velumani P Cureus. 2024; 16(7):e64251.

PMID: 39130901 PMC: 11314689. DOI: 10.7759/cureus.64251.

Kowalska J, Wrzesniok D Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065698 PMC: 11280276. DOI: 10.3390/ph17070847.

References

Bornstein S, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld A . Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020; 8(6):546-550. PMC: 7180013. DOI: 10.1016/S2213-8587(20)30152-2. View

Morales D, Morris A . Metformin in cancer treatment and prevention. Annu Rev Med. 2014; 66:17-29. DOI: 10.1146/annurev-med-062613-093128. View

Einhorn D, Rendell M, Rosenzweig J, EGAN J, Mathisen A, Schneider R . Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group. Clin Ther. 2001; 22(12):1395-409. DOI: 10.1016/s0149-2918(00)83039-8. View

Kim J, Ahn C, Fang S, Lee H, Park J . Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine (Baltimore). 2019; 98(46):e17918. PMC: 6867725. DOI: 10.1097/MD.0000000000017918. View

Crowley M, Diamantidis C, McDuffie J, Cameron C, Stanifer J, Mock C . Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review. Ann Intern Med. 2017; 166(3):191-200. PMC: 5293600. DOI: 10.7326/M16-1901. View

Campbell R, White Jr J, Saulie B . Metformin: a new oral biguanide. Clin Ther. 1996; 18(3):360-71; discussion 359. DOI: 10.1016/s0149-2918(96)80017-8. View

. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: . Diabetes Care. 2020; 44(Suppl 1):S40-S52. DOI: 10.2337/dc21-S004. View

Ekstrom N, Schioler L, Svensson A, Eeg-Olofsson K, Jonasson J, Zethelius B . Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open. 2012; 2(4). PMC: 3400073. DOI: 10.1136/bmjopen-2012-001076. View

Bahrambeigi S, Yousefi B, Rahimi M, Shafiei-Irannejad V . Metformin; an old antidiabetic drug with new potentials in bone disorders. Biomed Pharmacother. 2018; 109:1593-1601. DOI: 10.1016/j.biopha.2018.11.032. View

10.

Nkontchou G, Cosson E, Aout M, Mahmoudi A, Bourcier V, Charif I . Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. J Clin Endocrinol Metab. 2011; 96(8):2601-8. DOI: 10.1210/jc.2010-2415. View

11.

Johnson J, Majumdar S, Simpson S, Toth E . Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care. 2002; 25(12):2244-8. DOI: 10.2337/diacare.25.12.2244. View

12.

Zhang K, Yang W, Dai H, Deng Z . Cardiovascular risk following metformin treatment in patients with type 2 diabetes mellitus: Results from meta-analysis. Diabetes Res Clin Pract. 2020; 160:108001. DOI: 10.1016/j.diabres.2020.108001. View

13.

Maruthur N, Tseng E, Hutfless S, Wilson L, Suarez-Cuervo C, Berger Z . Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis. Ann Intern Med. 2016; 164(11):740-51. DOI: 10.7326/M15-2650. View

14.

Campbell I, Howlett H . Worldwide experience of metformin as an effective glucose-lowering agent: a meta-analysis. Diabetes Metab Rev. 1995; 11 Suppl 1:S57-62. DOI: 10.1002/dmr.5610110509. View

15.

Softeland E, Meier J, Vangen B, Toorawa R, Maldonado-Lutomirsky M, Broedl U . Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial. Diabetes Care. 2016; 40(2):201-209. DOI: 10.2337/dc16-1347. View

16.

Scott R, Loeys T, Davies M, Engel S . Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes. Diabetes Obes Metab. 2008; 10(10):959-69. DOI: 10.1111/j.1463-1326.2007.00839.x. View

17.

MacCallum L, Senior P . Safe Use of Metformin in Adults With Type 2 Diabetes and Chronic Kidney Disease: Lower Dosages and Sick-Day Education Are Essential. Can J Diabetes. 2018; 43(1):76-80. DOI: 10.1016/j.jcjd.2018.04.004. View

18.

Moioli A, Maresca B, Manzione A, Napoletano A, Coclite D, Pirozzi N . Metformin associated lactic acidosis (MALA): clinical profiling and management. J Nephrol. 2016; 29(6):783-789. DOI: 10.1007/s40620-016-0267-8. View

19.

de Wit L, Rademaker D, Voormolen D, Akerboom B, Kiewiet-Kemper R, Soeters M . SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial. BMJ Open. 2019; 9(8):e029808. PMC: 6701578. DOI: 10.1136/bmjopen-2019-029808. View

20.

Fonseca V, Rosenstock J, Patwardhan R, Salzman A . Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial. JAMA. 2001; 283(13):1695-702. DOI: 10.1001/jama.283.13.1695. View